"PCMA strongly supports real-time benefit tools, which not only provide visibility for patients but ensure providers consider the cost associated with therapeutically-equivalent medications."
Brendan Buck will assume the newly elevated role of Chief Communications Officer.
Williams brings over twenty years of experience in government affairs and public policy at both the state and national levels.
The legislation includes banning spread pricing and requiring PBMs to pass 100% of manufacturer rebates to health plans or patients.
PCMA voiced support for a series of legislative and regulatory reforms.
PCMA hailed the measure as a critical step toward fostering greater market competition and reducing drug costs.
PCMA argues the law is unconstitutional and may disrupt access to mail-order and specialty medications.
Kamal succeeds David Joyner, executive vice president of CVS Health and president of CVS Caremark, who completed his term as PCMA’s board chairman.
